Alpha-lipoic acid improves endothelial dysfunction in patients with subclinical hypothyroidism

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 9, 2010, Pages 625-629

  Xiang, G D ^a   Pu, J H ^a   Sun, H L ^a   Zhao, L S ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

antioxidant; endothelial dysfunction; subclinical hypothyroidism

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; EUTHYROIDISM; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZATION; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTIOXIDANTS; ASYMPTOMATIC DISEASES; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOCTIC ACID; VASODILATION;

EID: 77958139810     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1237702     Document Type: Article

References (29)

1. Kvetny J, Heldgaard PE, Bladbjerg RM, et al. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) 2004 61 232-238
2. Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 2004 89 3365-3370
3. Xiang GD, Sun HL, Cheng ZS, et al. Changes in plasma concentration of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients. J Clin Endocrinol Metab 2005 90 5765-5768
4. Taddei S, Caraccio N, Virdis A, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003 88 3731-3737
5. Förstermann U. Oxidative stress in vascular disease: Causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 2008 5 338-349
6. Nedelikovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J 2003 79 195-199
7. Taddei S, Caraccio N, Virdis A, et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimotos thyroiditis. J Clin Endocrinol Metab 2006 91 5076-5082
8. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow- mediated endothelium-dependent vasodilation of brachial artery. JACC 1999 34 146-154
9. Motoyama T, Kawano H, Kugiyama K, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998 32 1672-1679
10. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1987 52 302-310
11. Xiang GD, Wu YH. Apolipoprotein e4 allele and endothelium-dependent arterial dilation in type 2 diabetes mellitus without angiopathy. Diabetologia 2003 46 514-519
12. Xiang GD, Wang YL. Regular aerobic exercise training improves endothelium-dependent artery dilation in patients with impaired fasting glucose. Diabetes Care 2004 27 801-802
13. Xiang GD, Xu L, Zhao LS, et al. The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. Diabetes 2006 55 2126-2131
14. Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2003 139 866-867
15. Duman D, Sahin S, Esertas K, et al. Simvastatin improves endothelial function in patients with subclinical hypothyroidism. Heart Vessels 2007 22 88-93
16. Ferri C, Croce G, Cofini, et al. C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis. Curr Pharm Des 2007 13 1631-1645
17. Xiang GD, He YS, Zhao LS, et al. Impairment of endothelium-dependent arterial dilation in Hashimotos thyroiditis patients with euthyroidism. Clin Endocrinol (Oxf) 2006 64 698-702
18. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991 43 109-142
19. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-dependent vascular relaxing factor. Nature (Lond) 1986 320 454-456
20. Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol 1986 250 H815-H821
21. Xiang GD, Sun HL, Zhao LS, et al. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycemia during OGTT in impaired glucose tolerance. Clin Endocrinol (Oxf) 2008 68 716-723
22. Paolisso G, Tagliamonte MR, Barbieri M, et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type lldiabetic patients. J Clin Endocrinol Metab 2000 85 109-115
23. Title LM, Cummings PM, Giddens K, et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamin C and E. J Am Coll Cardiol 2000 36 2185-2191
24. 10 in health and disease. Eur J Clin Nutr 1999 53 764-770
25. Thomas SR, Witting PK, Stocker R. A role for reduced coenzyme Q in atherosclerosis? Biofactors 1999 9 207-224
26. 10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus. Diabetologia 2002 45 420-426
27. Reed LJ. From lipoic acid to multi-enzyme complexes. Protein Sci 1998 7 220-224
28. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004 21 114-121
29. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996 271 C1424-C1437